Nicotine effects on human endothelial intercellular communication via α4β2 and α3β2 nicotinic acetylcholine receptor subtypes.

Naunyn-Schmiedeberg's Archives of Pharmacology
Nicole DuerrschmidtStefan Dhein

Abstract

Since previous in vitro experiments revealed that nicotine can impair endothelial intercellular communication via the downregulation of connexin43 (Cx43), we wanted to find out which nicotinic acetylcholine receptors are involved in the molecular mechanism of communication failure. Cultured human endothelial cells were exposed to 1 μM nicotine for 5 days. Intercellular communication was measured using dye transfer study with/without subtype-specific nicotinic acetylcholine receptor (nAChR) inhibitors. Reverse transcriptase (RT)-PCR was used to further investigate the regulation of nAChR subtypes. Electron microscopy together with MAP LC3-II western blot was used to investigate possible autophagy processes. In cultured human endothelial cells, nicotine decreased the Cx43 protein amount as shown by western blot and immunohistochemistry; however, together with an unaltered mRNA expression as shown by RT-PCR. The nicotine-induced Cx43 downregulation functionally impaired intercellular dye transfer, which could be prevented by mecamylamine, κ-bungarotoxin, lobeline, and dihydro-β-erythroidine but not α-bungarotoxin, indicating that the nAChR subtypes α4β2 and α3β2 but not α7 are involved in signal cascade. RT-PCR analysis revealed t...Continue Reading

References

Dec 1, 1995·The Journal of Investigative Dermatology·S A GrandoB M Conti-Fine
Apr 1, 1995·American Journal of Respiratory and Critical Care Medicine·I WesslerK Racké
Jan 1, 1995·Annual Review of Physiology·D S McGehee, L W Role
Jan 1, 1994·Critical Reviews in Biochemistry and Molecular Biology·B M Conti-TronconiM P Protti
Mar 25, 2000·Trends in Pharmacological Sciences·F ClementiC Gotti
Apr 20, 2000·European Journal of Pharmacology·B M Conti-FineA D Maus
Mar 13, 2001·Japanese Journal of Pharmacology·C J KirkpatrickI Wessler
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·A B ElgoyhenJ Boulter
Sep 1, 2001·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·S DheinO E Brodde
Dec 26, 2001·Molecular Pharmacology·Frédéric SgardFrançois Besnard
Aug 22, 2002·The Journal of Clinical Investigation·Christopher HeeschenJohn P Cooke
Nov 19, 2002·Journal of Neurobiology·Nicolas Le NovèreJean-Pierre Changeux
Nov 19, 2002·Journal of Neurobiology·Michael W Quick, Robin A J Lester
Aug 29, 1957·The Journal of Physiology·B KATZ, S THESLEFF
Dec 20, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Wenguang ZhangJawahar L Mehta
Jun 28, 2005·Trends in Neurosciences·Rashid GiniatullinJerrel L Yakel
Jan 13, 2006·Biochemical and Biophysical Research Communications·Osamu TsukamotoMasafumi Kitakaze
Dec 13, 2006·Trends in Pharmacological Sciences·Steeve H ThanyBruno Lapied
May 27, 2008·British Journal of Pharmacology·I Wessler, C J Kirkpatrick
Dec 1, 2010·Methods in Molecular Biology·Christopher B McLelandStephan T Stern

❮ Previous
Next ❯

Citations

Nov 2, 2014·Naunyn-Schmiedeberg's Archives of Pharmacology·Stefan DheinFriedrich-Wilhelm Mohr
Jun 27, 2013·International Journal of Molecular Sciences·Lei Mao, Jacqueline Franke
Sep 22, 2017·Pharmacological Reviews·Luc LeybaertRainer Schulz
Jun 27, 2020·Neurological Research·Hiroaki KenmochiHiroki Namba
Nov 5, 2020·International Journal of Molecular Sciences·Kouji Fukuyama, Motohiro Okada

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms